Lipid profile changes in patients with COVID-19 referred to medical centers in Kermanshah, Iran; a case–control study

Objective To evaluate blood lipid profiles in patients with coronavirus disease 2019 (COVID-19), and to explore the association with disease severity. Methods This case–control study included patients with COVID-19, referred to two medical centers in Kermanshah, Iran (between July 2020 and December...

Full description

Bibliographic Details
Main Authors: Shahab Changaripour, Hosna Sarvazad, Maryam Barghi, Elham Sajadi, Mahdi Hashempour Sadeghian, Narges Eskandari Roozbahani
Format: Article
Language:English
Published: SAGE Publishing 2022-02-01
Series:Journal of International Medical Research
Online Access:https://doi.org/10.1177/03000605221078699
_version_ 1818759753085485056
author Shahab Changaripour
Hosna Sarvazad
Maryam Barghi
Elham Sajadi
Mahdi Hashempour Sadeghian
Narges Eskandari Roozbahani
author_facet Shahab Changaripour
Hosna Sarvazad
Maryam Barghi
Elham Sajadi
Mahdi Hashempour Sadeghian
Narges Eskandari Roozbahani
author_sort Shahab Changaripour
collection DOAJ
description Objective To evaluate blood lipid profiles in patients with coronavirus disease 2019 (COVID-19), and to explore the association with disease severity. Methods This case–control study included patients with COVID-19, referred to two medical centers in Kermanshah, Iran (between July 2020 and December 2020), and healthy controls. Lipid profiles were evaluated in patients who were grouped according to severe (intensive care unit [ICU]), or less severe (outpatient), forms of COVID-19, and in healthy controls, and were compared among the three groups. Results A total of 132 participants were included, comprising ICU ( n  = 49), outpatient ( n  = 48) and control ( n  = 35) groups. Mean cholesterol levels were lower in the patient groups than in controls; high-density lipoprotein cholesterol (HDL-C) levels were higher in the ICU group versus outpatients, and low-density lipoprotein cholesterol (LDL-C) levels were lower in the ICU group versus outpatients. The frequency of diabetes and hypertension was higher in the ICU group than in the outpatient group. Furthermore, LDL-C level was associated with disease severity (odds ratio 0.966, 95% confidence interval 0.944, 0.989). Conclusion Lipid profiles differ between severe and less severe forms of COVID-19. LDL-C level may be a useful indicator of COVID-19 severity.
first_indexed 2024-12-18T06:47:44Z
format Article
id doaj.art-aea152b1b39140619472d2d8f77abdad
institution Directory Open Access Journal
issn 1473-2300
language English
last_indexed 2024-12-18T06:47:44Z
publishDate 2022-02-01
publisher SAGE Publishing
record_format Article
series Journal of International Medical Research
spelling doaj.art-aea152b1b39140619472d2d8f77abdad2022-12-21T21:17:27ZengSAGE PublishingJournal of International Medical Research1473-23002022-02-015010.1177/03000605221078699Lipid profile changes in patients with COVID-19 referred to medical centers in Kermanshah, Iran; a case–control studyShahab ChangaripourHosna SarvazadMaryam BarghiElham SajadiMahdi Hashempour SadeghianNarges Eskandari RoozbahaniObjective To evaluate blood lipid profiles in patients with coronavirus disease 2019 (COVID-19), and to explore the association with disease severity. Methods This case–control study included patients with COVID-19, referred to two medical centers in Kermanshah, Iran (between July 2020 and December 2020), and healthy controls. Lipid profiles were evaluated in patients who were grouped according to severe (intensive care unit [ICU]), or less severe (outpatient), forms of COVID-19, and in healthy controls, and were compared among the three groups. Results A total of 132 participants were included, comprising ICU ( n  = 49), outpatient ( n  = 48) and control ( n  = 35) groups. Mean cholesterol levels were lower in the patient groups than in controls; high-density lipoprotein cholesterol (HDL-C) levels were higher in the ICU group versus outpatients, and low-density lipoprotein cholesterol (LDL-C) levels were lower in the ICU group versus outpatients. The frequency of diabetes and hypertension was higher in the ICU group than in the outpatient group. Furthermore, LDL-C level was associated with disease severity (odds ratio 0.966, 95% confidence interval 0.944, 0.989). Conclusion Lipid profiles differ between severe and less severe forms of COVID-19. LDL-C level may be a useful indicator of COVID-19 severity.https://doi.org/10.1177/03000605221078699
spellingShingle Shahab Changaripour
Hosna Sarvazad
Maryam Barghi
Elham Sajadi
Mahdi Hashempour Sadeghian
Narges Eskandari Roozbahani
Lipid profile changes in patients with COVID-19 referred to medical centers in Kermanshah, Iran; a case–control study
Journal of International Medical Research
title Lipid profile changes in patients with COVID-19 referred to medical centers in Kermanshah, Iran; a case–control study
title_full Lipid profile changes in patients with COVID-19 referred to medical centers in Kermanshah, Iran; a case–control study
title_fullStr Lipid profile changes in patients with COVID-19 referred to medical centers in Kermanshah, Iran; a case–control study
title_full_unstemmed Lipid profile changes in patients with COVID-19 referred to medical centers in Kermanshah, Iran; a case–control study
title_short Lipid profile changes in patients with COVID-19 referred to medical centers in Kermanshah, Iran; a case–control study
title_sort lipid profile changes in patients with covid 19 referred to medical centers in kermanshah iran a case control study
url https://doi.org/10.1177/03000605221078699
work_keys_str_mv AT shahabchangaripour lipidprofilechangesinpatientswithcovid19referredtomedicalcentersinkermanshahiranacasecontrolstudy
AT hosnasarvazad lipidprofilechangesinpatientswithcovid19referredtomedicalcentersinkermanshahiranacasecontrolstudy
AT maryambarghi lipidprofilechangesinpatientswithcovid19referredtomedicalcentersinkermanshahiranacasecontrolstudy
AT elhamsajadi lipidprofilechangesinpatientswithcovid19referredtomedicalcentersinkermanshahiranacasecontrolstudy
AT mahdihashempoursadeghian lipidprofilechangesinpatientswithcovid19referredtomedicalcentersinkermanshahiranacasecontrolstudy
AT nargeseskandariroozbahani lipidprofilechangesinpatientswithcovid19referredtomedicalcentersinkermanshahiranacasecontrolstudy